EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report

Debolina Pramanik, Divyashish Bhardwaj, Vikash K Karmani, Girindra G Raval, Abdullah Kutlar

Cureus · 25.07.2023

DOI: 10.7759/cureus.42423 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 25.07.2023. Verfasst von Debolina Pramanik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medicine, Medical College Kolkata, Kolkata, IND. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

caplacizumabplasmic scorerefractory thrombotic thrombocytopenic purpurarituximabsystemic lupus erythematosus

Autor:innen und Institutionen

  • Medicine, Medical College Kolkata, Kolkata, IND.
  • Medicine, Jawaharlal Nehru Medical College, Aligarh, IND.
  • Internal Medicine, Jinnah Sindh Medical University, Karachi, PAK.
  • Medicine: Hematology and Oncology, Medical College of Georgia at Augusta University, Augusta, USA.

Zitieren

APA

Pramanik, D., Bhardwaj, D., Karmani, V. K., Raval, G. G., & Kutlar, A. (2023). Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report. Cureus. https://doi.org/10.7759/cureus.42423

Vancouver

Pramanik D, Bhardwaj D, Karmani VK, Raval GG, Kutlar A. Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report. Cureus. 2023. doi:10.7759/cureus.42423

BibTeX
@article{Pramanik2023,
  author = {Pramanik, Debolina and Bhardwaj, Divyashish and Karmani, Vikash K and Raval, Girindra G and Kutlar, Abdullah},
  title = {Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report},
  journal = {Cureus},
  year = {2023},
  doi = {10.7759/cureus.42423}
}
Kostenlos starten →